Current Models of Risk Assessment Used in Biotechnology Regulation

November 1989
Citation:
19
ELR 10496
Issue
11
Author
Charles L. Elkins

I am not a biotechnology expert, but I will provide my personal views on the subject, arising from my involvement with the U.S. Environmental Protection Agency's (EPA) biotechnology regulation, through its Office of Toxic Substances.

First, I would like to give you my own perspective on the current status of EPA's biotechnology regulation. Second, I will consider an example of risk assessment, and finally, I will discuss the future direction of EPA's regulation.

Charles L. Elkins is Director, Office of Toxic Substances, U.S. Environmental Protection Agency.

Article File